1. Home
  2. TRMD vs LMAT Comparison

TRMD vs LMAT Comparison

Compare TRMD & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TORM plc

TRMD

TORM plc

HOLD

Current Price

$29.30

Market Cap

2.9B

ML Signal

HOLD

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$114.77

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRMD
LMAT
Founded
1889
1983
Country
United Kingdom
United States
Employees
N/A
655
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.6B
IPO Year
2016
2006

Fundamental Metrics

Financial Performance
Metric
TRMD
LMAT
Price
$29.30
$114.77
Analyst Decision
Buy
Buy
Analyst Count
1
5
Target Price
$34.00
$105.80
AVG Volume (30 Days)
854.6K
202.3K
Earning Date
05-13-2026
04-30-2026
Dividend Yield
7.12%
0.89%
EPS Growth
N/A
30.57
EPS
N/A
2.52
Revenue
N/A
$249,602,000.00
Revenue This Year
N/A
$14.21
Revenue Next Year
N/A
$8.88
P/E Ratio
$9.61
$44.76
Revenue Growth
N/A
13.53
52 Week Low
$14.93
$78.01
52 Week High
$31.76
$115.33

Technical Indicators

Market Signals
Indicator
TRMD
LMAT
Relative Strength Index (RSI) 59.27 67.23
Support Level $21.54 $81.60
Resistance Level $31.76 N/A
Average True Range (ATR) 0.96 3.25
MACD 0.21 -0.07
Stochastic Oscillator 75.80 96.20

Price Performance

Historical Comparison
TRMD
LMAT

About TRMD TORM plc

TORM plc operates as a shipping company mainly owning and operating a fleet of product tankers. It is engaged in the transportation of refined oil products and clean petroleum products, including gasoline, jet fuel, naphtha and diesel oil. The Company operates through two segments: the Tanker segment and the Marine Engineering segment, deriving the majority of its revenue from the Tanker segment.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Share on Social Networks: